← all combinations acute danger to life

GHB / GBL + Opioids

We recommend avoiding this combination. No numeric safety recommendation possible.

review pending

Content is undergoing medical and legal review. Changes possible.

Substances involved

Risk profile

Two different respiratory-depressant mechanisms acting on the respiratory center. Naloxone reverses only the opioid component, the GHB effect remains — rebound respiratory depression after naloxone wears off is real.

Acute emergency scenarios

Opioids (heroin, morphine, fentanyl, tilidine, tramadol) act on μ-opioid receptors and reduce respiratory drive. GHB/GBL acts GABAergically on the respiratory center. In combination, the respiratory depression is doubly unpredictable.

Clinically documented consequences:

  • Respiratory depression even at moderate dosing
  • Naloxone reverses only the opioid portion — GHB sedation remains
  • Delayed complications, because GHB breaks through again after the naloxone wears off

If opioid involvement is suspected: naloxone nasal spray (Nyxoid, OTC since 2024). But: don’t leave the person alone, even after naloxone has worked. Monitor breathing for hours.

In the chemsex context and in polydrug use, this combination is one of the most common causes of death — even in people who otherwise have well-established use habits.

We recommend avoiding this combination.